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SUMMARY
We assessed the role of tuberculosis (TB) disease and HIV infection on the level of physical
activity. A combined heart rate and movement sensor was used to assess habitual physical
activity in TB patients and non-TB controls. The association between sputum-negative TB,
sputum-positive TB, HIV and physical activity estimates were assessed in multivariable linear
regression models adjusted for age, sex, haemoglobin and alpha-1-acid glycoprotein (AGP).
Sputum-positive [eB 0·43, 95% conﬁdence interval (CI) 0·29–0·64] and sputum-negative (eB 0·67,
95% CI 0·47–0·94) TB as well as HIV infection (eB 0·59, 95% CI 0·46–0·75) were associated with
reduced activity compared to controls. Anaemia accounted for a substantial part of the effects of
HIV, while elevated AGP primarily mediated the TB effect. The level of physical activity is
highly inﬂuenced by TB and HIV, and mainly mediated through anaemia of infection and
associated with elevated acute phase response.
Key words: Epidemiology, HIV/AIDS, infectious disease epidemiology, lung infection,
tuberculosis (TB).
INTRODUCTION
One third of the world’s population is infected with
tuberculosis (TB) and about nine million people pro-
gress to TB disease every year, of which 2 million
die [1]. Sub-Saharan Africa has the highest incidence
with 290/100000 person-years [2]. It has been shown
that poor performance status (rated using a scoring
system) at the start of anti-TB treatment is a strong
predictor of early death in pulmonary TB patients
[3], but the relevance of habitual physical activity
and ﬁtness measured objectively has not been
reported.
In patients with TB, the level of physical activity
and ﬁtness may be markers of the severity of disease,
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as well as determinants of recovery. In ﬁnancially
disadvantaged settings, a swift recovery from disease
is crucial to enable the patient to return to work and
thereby support the family again.
As part of a large nutrition study in TB patients, we
measured ﬁtness using heart rate (HR) response to a
self-paced walk test and habitual physical activity
using combined accelerometry and HR monitoring
during >2 days of free living. In this paper we present
data on the role of TB disease and HIV infection and
other predictors on the level of physical activity and
indicators of physical ﬁtness.
METHODS
This paper is based on baseline data from a physical
activity study nested in two large nutrition studies in
TB patients [4, 5] conducted during 2006–2009
in Mwanza City, Tanzania. For a limited period all
TB patients admitted to Buzuruga Health Centre or
Sekou Toure Hospital for initiation of TB treatment
were invited to participate in the present substudy
on physical activity. In addition to TB patients,
non-TB neighbourhood controls were invited to
participate in the present study to enable further
comparisons. Physical activity was measured for all
156 TB patients and 26 controls who were invited to
participate.
The control group was selected from the neighbour-
hood of TB patients. The TB patients participating in
the nutrition studies were asked to provide detailed
contact information about their local chief, and in
cooperation with the chief a complete list of individ-
uals from the same cluster of houses (10–20 houses),
with the same sex and similar age (±5 years) as the
TB patient, was compiled. From the list one individ-
ual was randomly selected by lottery, and invited to
participate as control. None of the controls were
household contacts of a TB patient, and to be eligible
as a control, only adult (>15 years) participants were
invited. Furthermore, the controls were not eligible if
they had any history of TB, evidence of active TB
(cough, intermittent fevers, excessive night sweating
in the past 2 weeks, unexplained weight loss in the
past month), were pregnant or lactating, suffering
from other severe diseases, or non-residents of
Mwanza City. Their HIV status did not inﬂuence eli-
gibility. If the invited control was not eligible another
was randomly selected from the list. The recruitment
was performed on weekdays during daytime between
08:00 and 17:00 hours.
Prior to enrolment, the TB diagnosis in TB patients
was based on microscopy using Ziehl–Nielsen stained
specimen (for further details see [6]). Three additional
sputum samples were collected in sterile universal
bottles, and culture of Mycobacterium tuberculosis
was performed on Lowenstein–Jensen solid media
at the Zonal TB Reference Laboratory, Bugando
Medical Centre. TB diagnosis was based on the
culture result unless the sample was missing or con-
taminated in which case the microscopy result was
used. TB patients with veriﬁed bacteria were diag-
nosed as having sputum smear-positive TB (PTB+).
For TB subjects with a negative microscopy and
culture (PTB–), the TB diagnosis was based on
clinical suspicion, participant history, lack of clinical
improvement after treatment with a broad spectrum
of antibiotics, and X-ray results as suggested by
the WHO [7]. TB patients aged <15 years, pregnant
or lactating women, terminally ill patients (judged
unlikely to survive >48 h), suffering from other
severe diseases, as well as non-residents of Mwanza
City, were excluded. Participants not capable of
unassisted walking were excluded from the present
study. Except for the diagnosis of TB, all partici-
pants (TB and non-TB) underwent the same meas-
urements.
Height was measured to the nearest 0·1 cm and
weight to the nearest 0·1 kg with the patient barefoot
and wearing light clothing. Body mass index (BMI)
was deﬁned as weight/height2 (kg/m2). Venous blood
was collected and analysed at the National Institute
of Medical Research laboratory in Mwanza. All
participants were tested for HIV using two rapid tests,
Determine HIV 1/2 (Inverness Medical Innovations
Inc., USA) and Capillus HIV-1/HIV-2 (Trinity
Biotech plc., Ireland); if the results were discordant
a conﬁrmatory ELISA was performed. Cluster of
differentiation 4 (CD4) counts were determined by
ﬂow cytometry after CD4 immunoﬂourochrome
staining of the leucocytes (Partec FACS, Partec
GmbH, Germany). Haemoglobin was determined
and anaemia deﬁned as haemoglobin <12·0 g/dl in
women and <13·0 g/dl in men. Serum concentrations
of the acute phase reactant alpha-1-acid glycoprotein
(AGP) were determined at the Department of
Clinical Biochemistry, Aalborg University Hospital,
Denmark.
Upon arrival at the TB clinic during the morning,
TB patients as well as controls were set up with a
combined HR and movement (acceleration) sensor
(Actiheart, CamNtech Ltd, UK), as described
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Table 1. Background information, walk-test data and habitual physical activity in 135 pulmonary tuberculosis patients and 25 controls
Controls (n=25) PTB– (n=41) PTB+ (n=94)
PMean/% 95% CI Mean/% 95% CI Mean % 95% CI
Female sex, % 28·0 43·9 37·2 0·431
Age, years 37·5 32·2 to 42·8 42·0 38·0–45·9 33·5‡ 31·0–36·0 0·002
BMI, kg/m2 22·6 21·2 to 24·1 18·8† 18·1–19·6 18·4† 17·9–18·9 <0·001
Haemoglobin, g/dl 15·0 14·1 to15·9 9·7† 8·9–10·4 10·6† 10·1–11·1 <0·001
Anaemia, %* 8·0 87·8 79·8 <0·001
HIV positive, % 8·0 75·6 37·2 <0·001
CD4 count, cells/μl
HIV negative 584·7 474·9 to 694·6 794·5 352·3–1236·7 556·3 466·9–645·7 0·163
HIV positive 457·5 −19·0 to 934·0 400·3 307·6–492·9 359·8 281·3–438·3 0·711
Serum alpha-1-acid glycoprotein, g/l 0·8 0·7 to 0·9 2·0† 1·7–2·2 2·6†‡ 2·4–2·7 <0·001
Walk-test data
Walking speed, m/s 1·0 1·0 to 1·1 1·2 1·1–1·2 1·3†‡ 1·3–1·4 <0·001
Walking HR during walk, beats/min 99·0 92·5 to 105·5 122·3† 115·7–128·9 127·7† 124·0–131·4 <0·001
Walking HR above sleep during walk, beats/min 43·6 38·6 to 48·6 45·4 40·2–50·5 55·2†‡ 52·1–58·4 <0·001
HR during 90-s recovery period, beats/min 71·5 65·4 to 77·7 93·2† 88·9–97·5 97·3† 93·5–101·1 <0·001
HR above sleep during 90-s recovery period, beats/min 16·1 11·6 to 20·7 23·1 19·9–26·3 29·1† 26·1–32·2 <0·001
Walking distance per heart beat above sleep, m/beat 1·5 1·3 to 1·7 1·7 1·5–1·9 1·5 1·4–1·6 0·209
Habitual physical activity and HR
Sleeping HR, beats/min 55·4 51·5 to 59·3 76·9† 71·9–81·9 72·5† 69·7–75·3 <0·001
Acceleration, m/s2 0·11 0·09 to 0·1 0·04† 0·03–0·06 0·06† 0·05–0·07 <0·001
Sedentary activity intensity (<1·5 MET), h/day 15·0 13·9 to 16·1 19·0† 18·0–20·1 17·3†‡ 16·5–18·1 <0·001
Moderate and vigorous intensity (>3 MET), h/day 2·2 1·6 to 2·9 0·9† 0·6–1·1 1·2† 1·0–1·5 <0·001
Physical activity energy expenditure, kJ/kg per day [median (IQR)] 53·5 43·9 to 59·8 29·5† 14·7–42·2 37·6†‡ 18·7–70·9 <0·001
PTB–, Sputum smear-negative tuberculosis; PTB+, sputum smear-positive tuberculosis; CI, conﬁdence interval; BMI, body mass index; HR, heart rate; MET, metabolic
equivalent; IQR, interquartile range.
Data are mean (95% CI) or % unless otherwise stated.
* Anaemia deﬁned as haemoglobin <12·0 g/dl in women and <13·0 g/dl in men.
†Denotes different from control.
‡Denotes different from PTB–.
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elsewhere [8]. In the present study, the monitor was
attached to two ECG electrodes (Unomedical,
Australia) on the chest with the right patch placed
beneath the sternum, and the left patch at the medio-
clavicular line just beneath the left areola. The partici-
pants then completed a 300-m self-paced walk on a
ﬂat, ﬁrm ﬂoor, following which they relaxed for
2 min. Heart rate above sleep (HRaS) was calculated
as the difference between observed HR and sleeping
HR. Walk speed was calculated as distance (300 m)
divided by time taken, from which HR economy
(beats/metre) was derived as the ratio of walk HRaS
over walk speed; this parameter was used as the
main indicator of physical ﬁtness and as a means
of individually calibrating free-living HR data (see
below). After the walk test, the monitor was set-up
for long-term recording (collecting aggregated HR
and acceleration data every 30 s) and each participant
was thoroughly instructed in the local language
(Kiswahili) by a Tanzanian TB clinical ofﬁcer; in-
cluding information about duration of monitoring
(>2 days), basic functions of the monitor (HR, level
of movement), and reminding participants to wear
the monitor day and night, during showering and all
other activities.
Upon reappearance at the clinic, data were
downloaded and reviewed for lost data and erro-
neous information during the monitoring period.
If obvious recording errors had occurred, the par-
ticipant was asked to repeat the free-living monitor-
ing.
The free-living HR and accelerometer data were
cleaned and pre-processed using Gaussian process
regression for inferring the latent HR from the poten-
tially noisy HR data [9]. If no movement or non-
physiological HR was recorded for a prolonged
period, the period was marked as non-wear time.
Sleeping HR was determined from the days with com-
plete (24 h) measurements as reported previously [8].
For the estimation of free-living physical activity
energy expenditure (PAEE, in kJ/day per kg), we
modelled the activity and HR data using branched
equation modelling [10]. The estimation of activity
intensity from cleaned free-living data was determined
using group calibration equations for both accelero-
metry [11] and HR, the latter based on 1089 step
tests conducted in a population sample from Kenya
[12]. Intensity time-series were expressed in multiples
of resting metabolic rate [13], following which
sedentary time and moderate-to-vigorous activity
were quantiﬁed as proportion of time spent at
intensities <1·5 metabolic equivalents (METs) and
>3 METs, respectively.
Statistical analysis
All analyses were performed using Stata v. 11.2 stat-
istical software (StataCorp LP, USA). The t test and
one-way analysis of variance were used to test for
differences in means, and the χ2 test was used to test
for differences in proportions. The parameters from
the activity monitoring (i.e. sleeping HR, PAEE,
sedentary physical activity) were used as dependent
variables in linear regression models and with age,
sex, TB status, HIV status, the acute phase reactant
AGP and haemoglobin levels as independent vari-
ables. A normal haemoglobin levels was deﬁned as
>13 g/dl for men and >12 g/dl for women, while deﬁ-
cits of 0–2, 2–4, and >4 g/dl were used for increasingly
severe levels of anaemia (Table 2, model 3), whereas
AGP was dichotomized at 1·2 g/l to deﬁne elevated
response (Table 2, model 4). Since PAEE was not nor-
mally distributed, log-transformation (naturaal log-
arithm to the base e) was used to achieve a normal
distribution, thus the coefﬁcient (eB) should be inter-
preted as a ratio. PAEE parameters from free-living
measurements were adjusted for HR economy (meters
walked/heart beat) derived from the walk test to
account for the between-individual variance in HR–
PAEE relations. Interaction between HIV, TB, age
and sex was tested for. P values <0·05 were considered
signiﬁcant.
Ethical approval
Ethical permission was obtained from the ethics
committee of the National Institute for Medical
Research (NIMR) in Tanzania, and consultative
approval was given by The Danish National
Committee on Biomedical Research Ethics. Written
and oral information was presented to all eligible par-
ticipants by the health staff before written informed
consent was obtained, and all participants were
free to withdraw from the study at any time. Written
consent was obtained from parents/legal guardians
of any participants aged <18 years.
RESULTS
Of 156 TB patients and 26 non-TB controls recruited,
135 (86·5%) TB patients and 25 (96·2%) non-TB
controls had complete data on physical activity
and were included in the analyses. There were no
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Table 2. The association between physical activity parameters and infection, i.e. tuberculosis and HIV, in 25 non-tuberculosis controls and
135 tuberculosis patients
Model 1 Crude univariate
Model 2 Multivariable
adjusted for age and sex
Model 3 Multivariable
adjusted for age, sex,
haemoglobin
Model 4 Multivariable
adjusted for age, sex,
alpha-1-acid glycoprotein
eB 95% CI P eB 95% CI P eB 95% CI P eB 95% CI P
Physical activity energy expenditure, kJ/kg per min*
PTB– vs. non-tuberculosis control 0·43 0·29 to 0·64 <0·001 0·64 0·44–0·95 0·027 0·89 0·58 to 1·36 0·588 0·75 0·47 to 1·20 0·225
PTB+ vs. non-tuberculosis control 0·67 0·47 to 0·94 0·021 0·71 0·52–0·97 0·034 0·95 0·66 to 1·38 0·801 0·86 0·54 to 1·36 0·511
HIV+ vs. HIV– 0·59 0·46 to 0·75 <0·001 0·70 0·55–0·90 0·005 0·81 0·63 to 1·05 0·108 0·72 0·56 to 0·92 0·008
Haemoglobin (g/dl) 1·11 1·07 to 1·16 <0·001 — — — — — — — — —
Normal [>13 (men) and >12 (women) g/dl] ref. — — — — — ref. — — — — —
Anaemia level 1 (deﬁcit of 0–2 g/dl) 0·59 0·43 to 0·81 0·001 — — — 0·68 0·49 to 0·94 0·022 — — —
Anaemia level 2 (deﬁcit of 2–4 g/dl) 0·54 0·39 to 0·73 <0·001 — — — 0·66 0·47 to 0·92 0·014 — — —
Anaemia level 3 (deﬁcit of >4 g/dl) 0·40 0·29 to 0·56 <0·001 — — — 0·51 0·35 to 0·75 0·001 — — —
Alpha-1-acid glycoprotein (g/l) 0·78 0·68 to 0·88 <0·001 — — — — — — — — —
41·2 ref. — — — — — — — — ref. — —
>1·2 0·68 0·51 to 0·92 0·014 — — — — — — 0·80 0·54 to 1·19 0·278
B 95% CI P B 95% CI P B 95% CI P B 95% CI P
Sedentary physical activity, hours*
PTB– vs. non-tuberculosis control 4·0 2·2 to 5·9 <0·001 2·4 0·5–4·2 0·013 0·5 −1·5 to 2·5 0·638 1·9 −0·4 to 4·1 0·107
PTB+ vs. non-tuberculosis control 2·3 0·7 to 3·9 0·006 2·1 0·6–3·6 0·008 0·3 −1·4 to 2·0 0·715 1·4 −0·8 to 3·7 0·209
HIV+ vs. HIV– 2·3 1·1 to 3·4 <0·001 1·4 0·3–2·6 0·017 0·6 −0·6 to 1·8 0·298 1·4 0·2 to 2·5 0·023
Haemoglobin (g/dl) −0·6 −0·8 to −0·4 <0·001 — — — — — — — — —
Normal ref. — — — — — ref. — — — — —
Anaemia level 1 (deﬁcit of 0–2 g/dl) 2·8 1·4 to 4·3 <0·001 — — — 2·2 0·7 to 3·8 0·006 — — —
Anaemia level 2 (deﬁcit of 2–4 g/dl) 3·5 2·0 to 4·9 <0·001 — — — 2·7 1·1 to 4·3 0·001 — — —
Anaemia level 3 (deﬁcit of >4 g/dl) 4·6 3·1 to 6·2 <0·001 — — — 3·8 2·0 to 5·5 <0·001 — — —
Alpha-1-acid glycoprotein (g/l) 1·3 0·7 to 1·9 <0·001 — — — — — — — — —
41·2 ref. — — — — — — — — ref. — —
>1·2 1·9 0·5 to 3·3 0·009 — — — — — — 0·8 −1·1 to 2·7 0·433
Sleeping HR, beats/min
PTB– vs. non-tuberculosis control 21·5 14·6 to 28·4 <0·001 16·7 9·4–24·1 <0·001 9·9 1·9 to 17·9 0·016 8·3 −0·3 to 16·9 0·060
PTB+ vs. non-tuberculosis control 17·1 11·0 to 23·2 <0·001 15·1 9·1–21·1 <0·001 8·5 1·6 to 15·4 0·016 4·4 −4·1 to 12·9 0·310
HIV+ vs. HIV– 9·5 4·8 to 14·1 <0·001 4·7 0·1–9·4 0·044 2·5 −2·3 to 7·3 0·301 3·8 −0·7 to 8·3 0·101
Haemoglobin (g/dl) −2·7 −3·4 to −2·0 <0·001 — — — — — — — — —
Normal ref. — — — — — ref. — — — — —
Anaemia level 1 (deﬁcit of 0–2 g/dl) 13·9 8·2 to 19·6 <0·001 — — — 8·6 2·3 to 14·8 0·007 — — —
Anaemia level 2 (deﬁcit of 2–4 g/dl) 17·3 11·6 to 22·9 <0·001 — — — 10·8 4·5 to 17·1 0·001 — — —
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differences between TB patients and controls
with respect to age (mean difference of 1·4 years,
95% CI −4·1 to 7·0, P=0·61) or sex (60·7% vs. 72·0%
males, P=0·29). Of TB patients, 94 (69·6%) had
sputum-positive pulmonary TB (PTB+). More TB
patients than controls had HIV (48·9% vs. 8·0%,
P<0·001), as previously reported [4].
Background information, sleeping HR, walk test
parameters as well as free-living physical activity
data are shown in Table 1. With a walk speed of
1·3 m/s, the PTB+ patients had the fastest self-paced
walk speed, compared to controls (1·0 m/s, 95%
CI 0·9–1·1) and the PTB– patients (1·2 m/s, 95% CI
1·1–1·2), and, consequently, the PTB+ patients had
the highest HRaS during the walk test with a 11·6
(95% CI 4·9–18·4) and 9·9 (95% CI 4·3–15·5)
beats/min higher HR compared to the controls and
the PTB– patients, respectively. The walking distance
per heart beat, or the HR economy, based on this low-
intensity exercise (walk test) was similar for controls
and TB patients. During the non-clinical assessment
of physical activity, average movement measured by
the activity monitor’s accelerometer was 0·11 m/s2 in
controls, whereas the PTB+ and PTB– groups regis-
tered comparatively less movement, with measured
levels of 0·06 (95% CI 0·05–0·07) and 0·04 (95%
CI 0·03–0·06) m/s2, respectively. Similarly, median
PAEE was lower in PTB– and PTB+ patients (29·5
and 37·6 kJ/day per kg, respectively), compared to
controls (53·5 kJ/day per kg).
The associations between the TB disease and HIV
infection and outcomes derived from the activity
monitoring (i.e. PAEE, sedentary and moderate phys-
ical activity, sleeping HR) are shown in Table 2; with
model 1 showing crude estimates, and models 2, 3 and
4 showing adjusted multivariable models. Patients
with PTB– or PTB+ had a sleeping HR of 21·5
(95% CI 14·6–28·4) and 17·1 (95% CI 11·0–23·2)
beats/min higher than controls, and these estimates
were only marginally affected by age, sex and HIV
infection. Moreover, HIV infection was associated
with a higher sleeping HR (9·5, 95% CI 4·8–14·1
beats/min), but the difference decreased when adjust-
ing for TB, age and sex (Table 2, model 2). While
adjustment for haemoglobin halved the difference in
sleeping HR for TB disease and HIV infection
(Table 2, model 3), adjustment for AGP additionally
attenuated the difference in PTB+ patients (Table 2,
model 4). Although HIV infection was associated
with reduced CD4 count (Table 1), further adjustment
for CD4 count did not alter the results.T
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Patients with TB disease spent 2–4 h (P<0·01)
more in sedentary activities compared to controls,
and similarly, HIV infection was associated with
more sedentary activity (2·3, 95% CI 1·1–3·4) com-
pared to controls (Table 2). The increased time in
sedentary activities was associated with anaemia,
with those considered most anaemic (deﬁcit >4 g/dl)
spending almost 4 h more time on sedentary activities
compared to those with normal haemoglobin levels
(Table 2, model 3).
The average daily PAEE was less than half in the
PTB– patients (eB 0·43, 95% CI 0·29–0·64) and less
than two-thirds in PTB+ patients (eB 0·67, 95% CI
0·47–0·94) compared to controls (Table 2, model 1),
and this association was only partly confounded
by HIV infection (Table 2, model 2). Similarly,
HIV infection was associated with 41% lower levels
of activity compared to HIV uninfected participants
(eB 0·59, 95% CI 0·46–0·75), which was only partly
confounded by TB status. Anaemia was a strong
mediator of the association between TB, HIV and
physical activity (Table 2, model 3), while AGP pri-
marily seemed to mediate the role of TB on physical
activity (Table 2, model 4).
DISCUSSION
This is the ﬁrst study using combined movement
and HR monitoring in TB and HIV patients to assess
the level of PAEE and other activity measures. We
found that TB and HIV were associated with substan-
tially higher sleeping HR, and a marked reduction in
daily PAEE. Furthermore, anaemia was a strong
mediator of the effects from TB and HIV, while the
acute phase response primarily mediated the TB effect
on the physical activity parameters.
The role of the acute phase response and the
haemoglobin level indicates that the level of physical
activity is inversely associated with severity of infec-
tion, while sleeping HR (the inverse of which is a
marker of cardiorespiratory ﬁtness) is positively
associated with disease severity. Elevated serum
AGP could account for the associations between
TB, but not HIV, and performance. This is because
TB is accompanied by a considerable acute phase
response, whereas HIV per se is not. However, in
this study HIV infection was associated with anaemia,
which considerably reduces performance. Anaemia is
known to be associated with infection, and lower
levels in this study may therefore indicate either
more severe stages of the infection or longer time
living as treatment naive. Moreover, anaemia may
decrease aerobic capacity, and therefore reduce cap-
acity for performing daily activities as reﬂected in
PAEE. The association between HIV and physical
activity has previously been reported from a Kenyan
retrospective cohort study assessing the impact of
HIV/AIDS on individual labour productivity during
disease progression [14]. The study reported a decline
in work capacity by progressing HIV disease, and our
observations on objectively measured activity levels
corroborate these ﬁndings. In this study we consider
any anaemia to be caused primarily by TB and/or
HIV infection, although several other factors (e.g.
nutritional characteristics, other infections) could
similarly cause anaemia; however, such data were
not available from the study.
Bed rest is associated with a decrease in muscle
function [15], and since some of the TB subjects
with more severe disease could have been immobilized
for a prolonged period of time, this would most likely
lead to decreased activity energy expenditure, simply
due to inactivity and body tissue wasting. We have
previously demonstrated that TB patients may have
lost ∼10 kg of body weight due to the TB infection
prior to enrolment of TB diagnosis, treatment and,
hence, assessment of physical activity [16]. Elevated
sleeping HR is a common reaction to ongoing infec-
tions, both harmless and severe, but will reduce the
span between sleeping and maximum HR, and
hence reduce performance capacity.
The levels of physical activity and sleeping
HR seem most severely affected in PTB– patients.
Due to the lack of bacteria in the culture, it could
be postulated that PTB– patients were less severely
ill compared to PTB+. However, the group of PTB–
patients consists of HIV uninfected individuals with
early clinical manifestations of pulmonary TB as
well as severely immunosuppressed HIV-positive
infected patients, thus the PTB– group is very hetero-
geneous, and when adjusting the models for HIV
infection, the difference between PTB– and PTB+
became smaller.
In our study, sleeping HR is associated with severe
disease and could reﬂect increased metabolic demands
caused by the infections, thus leading to higher resting
energy expenditure. From a recent review it was
reported that HIV and associated infections increase
resting energy expenditure [17], and it is plausible to
assume that patients without access to sufﬁcient
nutrition intake will at some point reduce their activity
level to sustain the total energy expenditure in
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an attempt to avoid negative energy balance. Further-
more, it has been reported from a HIV study from
Kenya that disease progression leads to less physical
activity and less labour productivity [14]. Although
the lower activity level in HIV-infected individuals in
our study was mediated by anaemia, the activity
level remained reduced compared to HIV uninfected
individuals.
This study has several limitations. The choice of
control group was not optimal, since the control
group was recruited in a different time period than
the main study, but the controls were matched for
age and sex which should limit confounding. In
addition, average daily activity level observed in the
control group was similar to levels reported from
recent studies from Kenya [12] and Cameroon [18].
Another limitation is the estimation of PAEE by com-
bined sensing; although this is based on objective
measurements, several stages of inference is necessary
to estimate PAEE. The doubly labelled water tech-
nique is the gold standard for measuring the total
energy expenditure in humans under free-living con-
ditions [19, 20], which, if combined with an assess-
ment of resting energy expenditure, would provide
a more accurate estimate of PAEE; however, this
method is very expensive, and is difﬁcult to carry
out in large-scale studies. Furthermore, doubly
labelled water cannot quantify subcomponents of
physical activity like intensity, frequency and duration
[21], which may be deduced from combined move-
ment and HR data. The impact on behaviour from
awareness of wearing the device is potentially low,
since it is worn below the clothes and not clearly vis-
ible. Increased awareness of being monitored could
otherwise alter behaviour, i.e. the Hawthorne effect
[22]. Last, the method of individual calibration
could also be improved; a standardized and more
intense test, e.g. a treadmill test, may be a better test
than a walk test for calibrating the relationship
between HR and physical activity intensity at the
individual level [11], but this is less feasible in
fragile populations, e.g. the elderly or the sick. We
therefore opted for a self-paced walking test which
may capture around 50% of the between-individual
variance in the HR–PAEE relationship. All statistical
models were adjusted with an individual calibration
factor from the walk test but residual variance may
still persist which will have the effect of attenuating
associations towards the null; hence our results are
likely to be conservative estimates of the differences
in activity levels between these groups.
CONCLUSIONS
The level of PAEE and sleeping HR is highly
inﬂuenced by severe infections, such as TB and HIV.
The lower physical activity related to TB infection
is explained by increased acute phase response and
anaemia, whereas the association between HIV infec-
tion and physical activity was primarily mediated by
anaemia. A better understanding of the physical
activity level of individuals before and after TB treat-
ment is necessary, since this could help enable faster
recovery.
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